单位:[1]Georgia Hlth Sci Univ, Augusta, GA 30912 USA[2]Fourth Mil Med Univ, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China[3]Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China[4]Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China[5]Univ Maryland, Dept Mech Engn, Baltimore, MD 21201 USA[6]Huazhong Univ Sci & Technol, Tongji Hosp, Wuhan 430074, Peoples R China华中科技大学同济医学院附属同济医院[7]Univ Bandeirante Sao Paulo, Biomat Res Grp, Sao Paulo, Brazil[8]Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
Traditional bone regeneration strategies relied on supplementation of biomaterials constructs with stem or progenitor cells or growth factors. By contrast, cell homing strategies employ chemokines to mobilize stem or progenitor cells from host bone marrow and tissue niches to injured sites. Although silica-based biomaterials exhibit osteogenic and angiogenic potentials, they lack cell homing capability. Stromal cell-derived factor-1 (SDF-1) plays a pivotal role in mobilization and homing of stem cells to injured tissues. In this work, we demonstrated that 3-dimensional collagen scaffolds infiltrated with intrafibrillar silica are biodegradable and highly biocompatible. They exhibit improved compressive stress-strain responses and toughness over nonsilicified collagen scaffolds. They are osteoconductive and up-regulate expressions of osteogenesis-and angiogenesis-related genes more significantly than nonsilicified collagen scaffolds. In addition, these scaffolds reversibly bind SDF-1 alpha for sustained release of this chemokine, which exhibits in vitro cell homing characteristics. When implanted subcutaneously in an in vivo mouse model, SDF-1 alpha-loaded silicified collagen scaffolds stimulate the formation of ectopic bone and blood capillaries within the scaffold and abrogate the need for cell seeding or supplementation of osteogenic and angiogenic growth factors. Intrafibrillar-silicified collagen scaffolds with sustained SDF-1 alpha release represent a less costly and complex alternative to contemporary cell seeding approaches and provide new therapeutic options for in situ hard tissue regeneration.-Niu, L.-N., Jiao, K., Qi, Y.-P., Nikonov, S., Yiu, C. K. Y., Arola, D. D., Gong, S.-Q., El-Marakby, A., Carrilho, M. R. O., Hamrick, M. W., Hargreaves, K. M., Diogenes, A., Chen, J.-H., Pashley, D. H., Tay, F. R. Intrafibrillar silicification of collagen scaffolds for sustained release of stem cell homing chemokine in hard tissue regeneration. FASEB J. 26, 4517-4529 (2012). www.fasebj.org
基金:
U.S. National Institute of Dental and Craniofacial Research [R01-DE-015306-06]; Georgia Health Sciences University Extramural Success Award; Innovative Pilot Project in Regenerative Medicine; National Nature Science Foundation of China [81130078]; National Key Basic Research Program of China [2012CB526704]; National Center for Research Resources, U.S. National Institutes of Health [P40-RR-017447]
Niu Li-Na,Jiao Kai,Qi Yi-Pin,et al.Intrafibrillar silicification of collagen scaffolds for sustained release of stem cell homing chemokine in hard tissue regeneration[J].FASEB JOURNAL.2012,26(11):4517-4529.doi:10.1096/fj.12-210211.
APA:
Niu, Li-Na,Jiao, Kai,Qi, Yi-Pin,Nikonov, Sergey,Yiu, Cynthia K. Y....&Tay, Franklin R..(2012).Intrafibrillar silicification of collagen scaffolds for sustained release of stem cell homing chemokine in hard tissue regeneration.FASEB JOURNAL,26,(11)
MLA:
Niu, Li-Na,et al."Intrafibrillar silicification of collagen scaffolds for sustained release of stem cell homing chemokine in hard tissue regeneration".FASEB JOURNAL 26..11(2012):4517-4529